| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.0088 | 1 |